Vericel Corporation Stock Prediction
AI-powered sentiment analysis and prediction trends for VCEL, updated each market day.
VCEL AI Sentiment
AI sees no strong directional signal for Vericel Corporation stock over the next 10 market days.
Prediction date: Sept. 21, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Sector
Exchange
Market Cap
$2,049,800,758
Cap Tier
Employees
398
Headquarters
BURLINGTON, MA
Listed Since
Feb. 4, 1997
Website
VCEL Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
VCEL Volatility
Vericel Corporation has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
